Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.15, Iss.10, 2008-10, pp. : 2887-2893

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pattern of recurrence in paediatric malignant glioma: an institutional experience

By Vaidya Sucheta Hargrave Darren Saran Frank Britton Juliet Soomal Rubin Bouffet Eric

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 279-284

Springer Publishing Company

Access to resources Recommend Favorite

A Single Centre's 10 Year Experience With Isolated Limb Perfusion in the Treatment of Recurrent Malignant Melanoma of the Limb

By Lingam M.K. Byrne D.S. Aitchison T. MacKie R.M. McKay A.J.

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1668-1673

Elsevier

Access to resources Recommend Favorite

Malignant Mixed Mesodermal Ovarian Tumor Treatment and Prognosis: A 20-Year Experience

By Le T. Krepart G.V. Lotocki R.J. Heywood M.S.

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 237-240

Elsevier

Access to resources Recommend Favorite

Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma

By Jenkinson Michael Smith Trevor Haylock Brian Husband David Shenoy Aditya Vinjamuri Sobhan Walker Carol Pietronigro Denis Warnke Peter

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite

Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma

By Storm Phillip Renard Violette Moriarity John Tyler Betty Wilentz Robb Brem Henry Weingart Jon

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 361-367

Springer Publishing Company

Access to resources Recommend Favorite